Literature DB >> 33070883

Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.

Ramin A Morshed1, Adib A Abla1, Daniel Murph2, Jasmin M Dao3, Ethan A Winkler1, Jan-Karl Burkhardt4, Kathleen Colao3, Steven W Hetts2, Heather J Fullerton3, Michael T Lawton5, Nalin Gupta1, Christine K Fox6.   

Abstract

Moyamoya is a progressive cerebrovascular arteriopathy that affects children of any age. The goal of this study was to determine imaging and clinical outcomes as well as complication rates in a pediatric cohort undergoing either a combined direct/indirect or indirect-only revascularization approach. Patients with moyamoya disease or syndrome ≤ 18 years of age at the time of initial surgery were identified, and clinical data were collected retrospectively. Over a 12-year period, 26 patients underwent revascularization procedures on 49 hemispheres with a median follow-up of 2.6 years from surgery. Median age at surgery was 7.3 years (range 1.4-18.0 years). Thirty-three hemispheres (67.3%) underwent combined revascularization with a direct bypass and encephalomyosynangiosis, and sixteen hemispheres (32.7%) underwent indirect-only revascularization. The rate of 30-day perioperative complication was 10.2%, and the rate of postoperative clinical stroke by end of follow-up was 10.2% by hemisphere. There was a 5.7% rate of intraoperative bypass failure requiring conversion to an indirect revascularization approach. On follow-up imaging, 96.9% of direct bypasses remained patent. On multivariate analysis, higher preoperative Pediatric Stroke Outcome Measure (PSOM) scores were associated with lower rates of good clinical outcome on follow-up (unit OR 0.03; p = 0.03). Patients with age < 5.4 years had lower rates of good clinical outcome on follow-up. In this North American cohort, both combined direct/indirect and indirect only revascularization techniques were feasible. However, younger children < 5.4 years of age have worse outcomes than older children, similar to east Asian cohorts.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Direct and indirect revascularization technique; Moyamoya disease; STA-MCA bypass; Vascular disorders

Year:  2020        PMID: 33070883      PMCID: PMC7573194          DOI: 10.1016/j.jocn.2020.07.016

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  22 in total

1.  Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.

Authors:  Yong Zhang; Xiang-Yang Bao; Lian Duan; Wei-Zhong Yang; De-Sheng Li; Zheng-Shan Zhang; Cong Han; Feng Zhao; Qian Zhang; Qian-Nan Wang
Journal:  J Neurosurg Pediatr       Date:  2018-06-01       Impact factor: 2.375

2.  Moyamoya: defining current knowledge gaps.

Authors:  Vijeya Ganesan; Edward R Smith
Journal:  Dev Med Child Neurol       Date:  2015-02-13       Impact factor: 5.449

3.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

4.  Surgical management of moyamoya syndrome.

Authors:  Edward R Smith; R Michael Scott
Journal:  Skull Base       Date:  2005-02

5.  Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.

Authors:  Gyang Markus Bot; Jan-Karl Burkhardt; Nalin Gupta; Michael T Lawton
Journal:  J Neurosurg Pediatr       Date:  2018-11-16       Impact factor: 2.375

6.  Postoperative neurological deterioration following the revascularization surgery in children with moyamoya disease.

Authors:  T Sakamoto; M Kawaguchi; K Kurehara; K Kitaguchi; H Furuya; J Karasawa
Journal:  J Neurosurg Anesthesiol       Date:  1998-01       Impact factor: 3.956

Review 7.  Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions.

Authors:  Anand Veeravagu; Raphael Guzman; Chirag G Patil; Lewis C Hou; Marco Lee; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

8.  Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management.

Authors:  Sherif Rashad; Miki Fujimura; Kuniyasu Niizuma; Hidenori Endo; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2016-05-16       Impact factor: 3.042

9.  Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment.

Authors:  Seung-Ki Kim; Ho Jun Seol; Byung-Kyu Cho; Yong-Seung Hwang; Dong Soo Lee; Kyu-Chang Wang
Journal:  Neurosurgery       Date:  2004-04       Impact factor: 4.654

Review 10.  Moyamoya disease: a summary.

Authors:  Gordon M Burke; Allan M Burke; Arun K Sherma; Michael C Hurley; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

View more
  2 in total

Review 1.  Characteristics of Moyamoya Disease in the Older Population: Is It Possible to Define a Typical Presentation and Optimal Therapeutical Management?

Authors:  Ignazio G Vetrano; Anna Bersano; Isabella Canavero; Francesco Restelli; Gabriella Raccuia; Elisa F Ciceri; Giuseppe Faragò; Andrea Gioppo; Morgan Broggi; Marco Schiariti; Laura Gatti; Paolo Ferroli; Francesco Acerbi
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

Review 2.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.